Dr Steven Petratos with his poster |
"Dr Petratos, who undertook the only Australian-led project from this round of funding, was investigating the role of a molecule called Nogo-A in nerve fibre damage in progressive MS. The researchers were aiming to block Nogo-A by delivering agents directly to the brain and spinal cord to hopefully limit MS-like disease in laboratory models of MS. The research team investigated the role of the Nogo-A related gene (known as NgR1) in nerve fibre degeneration and found that by blocking this gene they could limit nerve fibre damage and the subsequent neurodegeneration."
- Link to full report.
- See more about Steven Petratos's research
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.